Glaxo, Theravance Wine Approval For Lung Disease Treatment by Anna Edney. Bloomberg. May 10, 2013.
(1) COPD is the _______-leading cause of death.
(2) COPD is an umbrella term for __________ and ______ ________.
(3) Breo is unlike its main competitors in that it is taken ________ a day.
(4) Breo works by decreasing _________ and helping airways stay _________.
(5) The therapy was produced by a partnership of ________ and ___________>
No comments:
Post a Comment